Creative Planning’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1M Buy
35,183
+4,686
+15% +$102K ﹤0.01% 2638
2026
Q1
$529K Buy
30,497
+917
+3% +$17.4K ﹤0.01% 2992
2025
Q4
$557K Buy
29,580
+1,593
+6% +$26.7K ﹤0.01% 2742
2025
Q3
$407K Buy
+27,987
New +$399K ﹤0.01% 2903
2024
Q4
Sell
-6,537
Closed -$204K 3605
2024
Q3
$204K Buy
+6,537
New +$163K ﹤0.01% 2820
2023
Q2
Sell
-53
Closed -$485 2680
2023
Q1
$485 Buy
+53
New +$678 ﹤0.01% 2588

Other funds holding CDNA

Creative Planning's CDNA Position: Q2 2026 in Review

Creative Planning increased its CareDx (CDNA) stake by 15% in Q2 2026, buying an estimated $102K and bringing the position to 35,183 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #2638.

Creative Planning first reported a position in CDNA in Q1 2023 and has held it in 6 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Creative Planning held 35,183 shares of CareDx worth $1M as of Q2 2026.
  • Creative Planning bought 4,686 CareDx shares in Q2 2026, an estimated $102K.
  • CareDx made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2638 holding.
  • Creative Planning first reported a position in CareDx in Q1 2023 and has held it in 6 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.